Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RCL vs MRNA✓SelectedUSD · MRNARCL vs MRNA performance historyLatest closeAs of-2.20%11/20
Stock and ETF performance explorer

RCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+204.6%
MRNA return
+786.4%
Excess return
-581.8%
Maximum drawdown
-83.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%-2.2%0.0%-2.1%
7D-8.3%-12.7%+4.4%-7.9%
30D+2.8%-20.7%+23.5%+3.5%
3M+3.7%+46.3%-42.6%+2.1%
6M+18.1%+305.2%-287.2%+8.3%
YTD+8.1%+561.2%-553.2%-3.9%
1Y+19.7%+772.1%-752.4%+4.8%
3Y+189.8%+147.0%+42.9%+163.0%
5Y+281.1%-26.1%+307.2%+237.8%
All+204.6%+786.4%-581.8%+200.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling